Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2025)

Nurix Therapeutics (NRIX) has 4 years of Receivables - Net data on file, last reported at $19.0 million in Q2 2025.

• Receivables - Net for Q2 2025 came in at $19.0 million, changed N/A year-over-year; the trailing twelve-month figure through May 2025 was $19.0 million (changed N/A YoY), and the FY2021 annual result was $6.0 million, changed N/A from the prior year.
• Receivables - Net grew to $19.0 million in Q2 2025 per NRIX's latest filing, from $2.0 million in the prior quarter.
• Over five years, Receivables - Net peaked at $19.0 million in Q2 2025 and troughed at $6000.0 in Q1 2022.
• A 4-year average of $5.9 million and a median of $2.5 million in 2021 frame the typical range for Receivables - Net.